M Michelle Berrey Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

M Michelle Berrey is President, R&D and CMO of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 51,790 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $984,010. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

M Michelle Berrey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$984,010 $19.0 p/Share	51,790 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$538,631 $19.0 p/Share	28,349 Reduced 100.0%	0 Common Stock
Sep 14 2023	SELL Payment of exercise price or tax liability	$14,416 $11.57 p/Share	1,246 Reduced 1.53%	80,139 Common Stock
Jun 14 2023	SELL Payment of exercise price or tax liability	$15,001 $12.04 p/Share	1,246 Reduced 1.51%	81,385 Common Stock
Mar 14 2023	SELL Payment of exercise price or tax liability	$19,674 $15.79 p/Share	1,246 Reduced 1.49%	82,631 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	14,700 Added 14.91%	83,877 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$9,463 $12.37 p/Share	765 Reduced 1.09%	69,177 Common Stock
Dec 14 2022	SELL Payment of exercise price or tax liability	$18,615 $14.94 p/Share	1,246 Reduced 1.75%	69,942 Common Stock
Sep 14 2022	SELL Payment of exercise price or tax liability	$21,356 $17.14 p/Share	1,246 Reduced 1.72%	71,188 Common Stock
Jun 14 2022	SELL Payment of exercise price or tax liability	$60,306 $12.1 p/Share	4,984 Reduced 6.44%	72,434 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	10,300 Added 11.74%	77,418 Common Stock
Jun 14 2021	BUY Grant, award, or other acquisition	-	67,118 Added 50.0%	67,118 Common Stock

Also insider at

AEHA

Aesther Healthcare Acquisition Corp. Financial Services

Director

MMB